Piramal Pharma Ltd

Piramal's Global Pharma business is comprised of Piramal Pharma Solutions (PPS) and Piramal Critical Care (PCC). PPS is a contract development and manufacturing organization (CDMO), offering end-to-end development and manufacturing solutions across the drug life cycle. We serve our clients through a globally integrated network of facilities in North America, Europe and Asia. This enables us to offer a comprehensive range of services including Drug Discovery Solutions, Process & Pharmaceutical Development services, Clinical Trial Supplies, Commercial supply of APIs and Finished dosage forms. We also offer specialized services like development and manufacture of Highly Potent APIs and Antibody Drug Conjugation. Our capability as an integrated service provider & experience with various technologies enables us to serve Innovator and Generic companies worldwide. PCC is a leading global player in the hospital generics segment. PCC is the world's third largest producer of inhaled anesthetics. The business has marketing presence in over 100 countries with manufacturing locations in the US and India. PCC’s product portfolio includes inhalation anesthetics, injectable anesthesia and pain management products as well as other critical care products including plasma volume expanders. Our commitment to quality is supported with global regulatory approvals that are accredited to our manufacturing plants in the US and India. Their strategic location enables us to supply products throughout the world with great flexibility, helping us adhere to our commitment of uninterrupted delivery.

Lead Quality , Regulatory and Pharmacovigilance globally for 17 sites located in USA, Europe, Canada and India, Satellite offices and distribution at >100 countries, CMOs located in USA, Europe and India. Lead Regulatory affairs and compliance for Piramal Pharmasolutions and Consumer products division with product registrations with FDA, MHRA, EMEA, PMDA and several RoW countries.